The generic name for Keppra is levetiracetam [1].
What is levetiracetam used for?
Levetiracetam is an anticonvulsant medication used to treat partial-onset seizures in adults and children [2]. It is also prescribed for myoclonic seizures in individuals with juvenile myoclonic epilepsy and for generalized tonic-clonic seizures in people with epilepsy [2].
How does levetiracetam work?
The exact mechanism of action for levetiracetam is not fully understood [3]. However, it is believed to bind to a synaptic vesicle protein, SV2A, which is thought to be involved in the regulation of neurotransmitter release [3].
When does levetiracetam's patent expire?
Information on the specific patent expiry dates for levetiracetam can be found through patent databases [4]. These databases track patent filings, grants, and expirations for pharmaceuticals.
Are there other brand names for levetiracetam?
While Keppra is the most widely recognized brand name, other pharmaceutical companies may market levetiracetam under different brand names [1]. Generic versions of levetiracetam are also available from various manufacturers [1].
What are the common side effects of levetiracetam?
Common side effects associated with levetiracetam include drowsiness, dizziness, fatigue, and behavioral changes such as irritability and mood disturbances [2].
Who manufactures Keppra?
Keppra was originally developed by UCB Pharma [5].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.nhs.uk/medicines/levetiracetam/
[3] https://www.ncbi.nlm.nih.gov/books/NBK534870/
[4] https://www.drugpatentwatch.com/
[5] https://www.ucb.com/